|
|
Volumn 375, Issue 9718, 2010, Pages 893-
|
|
The Health Impact Fund
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GENERIC DRUG;
IVERMECTIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DIARRHEA;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
FUNDING;
HEALTH CARE;
HEALTH CARE PLANNING;
HUMAN;
INTERNATIONAL COOPERATION;
LETTER;
ONCHOCERCIASIS;
ORAL REHYDRATION THERAPY;
ORGANIZATION;
PATENT;
PRIORITY JOURNAL;
PROGRAM DEVELOPMENT;
WORLD HEALTH ORGANIZATION;
DEVELOPING COUNTRY;
DRUG COST;
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
DEVELOPING COUNTRIES;
DRUG COSTS;
DRUG INDUSTRY;
FINANCING, ORGANIZED;
HUMANS;
INTERNATIONAL COOPERATION;
PATENTS AS TOPIC;
|
|
EID: 77749301188
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(10)60386-8 Document Type: Letter |
|
Times cited : (1)
|
|
References (2)
|
